|
|
Volumn 78, Issue 2, 2014, Pages 75-76
|
|
Strontium ranelate lives to fight another day
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
C REACTIVE PROTEIN;
DENOSUMAB;
PLACEBO;
STRONTIUM RANELATE;
BONE DENSITY CONSERVATION AGENT;
ORGANOMETALLIC COMPOUND;
STRONTIUM;
THIOPHENE DERIVATIVE;
ARTERY THROMBOSIS;
BONE TURNOVER;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CEREBROVASCULAR DISEASE;
DIABETES MELLITUS;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
FRAGILITY FRACTURE;
HEART INFARCTION;
HIP FRACTURE;
HUMAN;
HYPERLIPIDEMIA;
ISCHEMIC HEART DISEASE;
JAW OSTEONECROSIS;
OSTEOARTHRITIS;
OSTEOPOROSIS;
PERIPHERAL OCCLUSIVE ARTERY DISEASE;
POSTMENOPAUSE;
SKIN MANIFESTATION;
SPINE FRACTURE;
VENOUS THROMBOEMBOLISM;
DRUG APPROVAL;
BONE DENSITY CONSERVATION AGENTS;
DRUG APPROVAL;
HUMANS;
ORGANOMETALLIC COMPOUNDS;
OSTEOPOROSIS;
STRONTIUM;
THIOPHENES;
|
|
EID: 84901248769
PISSN: 03785122
EISSN: 18734111
Source Type: Journal
DOI: 10.1016/j.maturitas.2014.03.011 Document Type: Editorial |
|
Times cited : (11)
|
|
References (3)
|
